Trends in resistance to penicillin and erythromycin of invasive pneumococci in Portugal

Epidemiology and Infection

Volumn 136, Issue 7, 2008, Pages 928-939

  Dias, R ^a   Caniça, Manuela ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFATRIZINE; CEFIXIME; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CLARITHROMYCIN; ERYTHROMYCIN; FLUCLOXACILLIN; LINCOSAMIDE; MACROLIDE; PENICILLIN G; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; STREPTOGRAMIN; TELITHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG USE; HUMAN; LINEAR REGRESSION ANALYSIS; NONHUMAN; PORTUGAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; INFANT; INFANT, NEWBORN; MACROLIDES; MENINGOCOCCAL VACCINES; MIDDLE AGED; MODELS, STATISTICAL; PENICILLINS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PORTUGAL; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 44049108924     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268807009405     Document Type: Article

References (39)

1. Klugman KP. The successful clone: The vector of dissemination of resistance in Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 2002; 50: 1-5.
2. Klein JO. The epidemiology of pneumococcal disease in infants and children. Reviews of Infectious Diseases 1981; 3: 246-253.
3. Felmingham D, et al. Surveillance of resistance in bacteria causing community-acquired respiratory tract infections. Clinical Microbiology and Infection 2002; 8 (Suppl. 2): 12-42.
4. Goossens H, et al. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet 2005; 365: 579-587.
5. Bruinsma N, et al. Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe. Journal of Antimicrobial Chemotherapy 2004; 54: 1045-1050.
6. Dias R, Louro D, Caniça M. Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period. Antimicrobial Agents and Chemotherapy 2006; 50 2098-2105.
7. Dias R, Caniça M. Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: Contribution and phylogenetic relatedness of serotype 14. Journal of Antimicrobial Chemotherapy 2004; 54: 1035-1039.
8. Whitney CG, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. New England Journal of Medicine 2003; 348: 1737-1746.
9. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: Approved standard M100-S17. Wayne, PA: NCCLS, 2007.
10. Fenoll A, et al. Dot blot assay for the serotyping of pneumococci. Journal of Clinical Microbiology 1997; 35: 764-766.
11. World Health Organization. The anatomical therapeutic chemical classification system with defined daily doses (ATC/DDD). 2005 (http://www.whocc.no/atcddd/indexdatabase/). Accessed 22 March 2005.
12. Falcão JM, et al. Antimicrobial use in the community: A surveillance study from Médicos-Sentinela. Revista Portuguesa de Clínica Geral 2003; 19: 315-329.
13. Belsley DA, et al. Regression Diagnostics: Identifying Influential Data and Sources of Collinearity. New York: John Wiley & Sons, 1980, pp. 11-18.
14. Sociedade Portuguesa de Pediatria. Meningococcal and pneumococcal conjugate vaccines. Recommendations of the Pediatric Infectiology from the Portuguese Pediatric Society. Acta Pediátrica Portuguesa 2003; 34: 373-375.
15. De Queirós L, et al. Acceptance of the new conjugate vaccines. Meningococcal and pneumococcal vaccines, in the cohort born in 1999, in the North Region of Portugal. Acta Médica Portuguesa 2004; 17: 49-53.
16. Ready D, et al. Effect of amoxicillin use on oral microbiota in young children. Antimicrobial Agents and Chemotherapy 2004; 48: 2883-2887.
17. Dancer SJ. The problem with cephalosporins. Journal of Antimicrobial Chemotherapy 2001; 48: 463-478.
18. Canet JJ, Garau J. Importance of dose and duration of beta-lactam therapy in nasopharyngeal colonization with resistant pneumococci. Journal of Antimicrobial Chemotherapy 2002; 50 (Suppl. 2): 39-43.
19. Arason VA, et al. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. British Medical Journal 1996; 313: 387-391.
20. Baquero F, et al. Antibiotic consumption and resistance selection in Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 2002; 50 (Suppl. 2): 27-37.
21. Barkai G, et al. Community prescribing and resistant Streptococcus pneumoniae. Emerging Infectious Diseases 2005; 11 829-837.
22. Bronzwaer SL, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerging Infectious Diseases 2002; 8: 278-282.
23. Nightingale CH. Pharmacokinetics and pharmacodynamics of newer macrolides. Pediatric Infectious Disease Journal 1997; 16: 438-443.
24. Kastner U, Guggenbichler JP. Influence of macrolide antibiotics on promotion of resistance in the oral flora of children. Infection 2001; 29: 251-256.
25. Ghaffar F, et al. Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media. Clinical Infectious Diseases 2000; 31: 875-880.
26. Kosowska-Shick K, et al. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents. Antimicrobial Agents and Chemotherapy 2006; 50: 2064-2071.
27. Lipsitch M. Vaccination against colonizing bacteria with multiple serotypes. Proceedings of the National Academy of Sciences USA 1997; 94: 6571-6576.
28. Dagan R, et al. Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees. Pediatric Infectious Disease Journal 2001; 20: 951-958.
29. Frazão N, et al. Effect of the seven-valent conjugate pneumococcal vaccine on carriage and drug resistance of Streptococcus pneumoniae in healthy children attending day-care centers in Lisbon. Pediatric Infectious Disease Journal 2005; 24: 243-252.
30. Temime L, Guillemot D, Boelle PY. Short- and longterm effects of pneumococcal conjugate vaccination of children on penicillin resistance. Antimicrobial Agents and Chemotherapy 2004; 48: 2206-2213.
31. Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: The key to pneumococcal disease. Lancet Infectious Diseases 2004; 4: 144-154.
32. Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357: 1851-1853.
33. Reinert RR. Pneumococcal conjugate vaccines - a European perspective. International Journal of Medical Microbiology 2004; 294: 277-294.
34. Caniça M, et al. In vitro activity of extended-spectrum cephalosporins against Streptococcus pneumoniae strains with reduced susceptibility to penicillin isolated from patients in Portugal between 1995 and 2000. Journal of Antimicrobial Chemotherapy 2002; 50: 611-612.
35. WHO. Antimicrobial and support therapy for bacterial meningitis in children. Report of the meeting of 18-20. June 1997, Geneva, Switzerland, 1998 (http://www.who.int/entity/csr/resources/publications/ meningitis/whoemcbac982.pdf). Accessed 28 January 2005.
36. Walsh F, et al. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae. Journal of Antimicrobial Chemotherapy 2004; 53: 793-796.
37. Reinert RR, van der Linden M, Al-Lahham A. Molecular characterization of the first telithromycin-resistant Streptococcus pneumoniae isolate in Germany. Antimicrobial Agents and Chemotherapy 2005; 49: 3520-3522.
38. Caniça M, et al. Two major Spanish clones of penicillin-resistant Streptococcus pneumoniae in Portuguese isolates of clinical origin. Journal of Antimicrobial Chemotherapy 2003; 51: 409-414.
39. Pozzi G, et al. Genetic elements carrying macrolide efflux genes in streptococci. Current Drug Targets - Infectious Disorders 2004; 4: 203-206.